Navigation Links
Helix BioPharma announces $16.9 million private placement of common shares
Date:12/17/2007

AURORA, Ontario, Dec. 17 /PRNewswire-FirstCall/ - Helix BioPharma Corp. (TSX, FSE: "HBP") today announced that it has received subscriptions for the purchase, by way of private placement, of a total of 10,040,000 common shares at $1.68 per share, for gross proceeds totaling CDN$16,867,200. Proceeds from the placement will be used for working capital, primarily to fund the Company's research and development initiatives.

The Company expects to close the private placement within the next ten days.

About Helix BioPharma Corp.

Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. The Company is actively developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix's product development initiatives include its Topical Interferon Alpha-2b and its novel L-DOS47 new drug candidate. Helix is listed on the TSX under the symbol "HBP" and quoted on the Frankfurt, Berlin, Munich and Stuttgart Stock Exchanges under the same symbol.

The Toronto Stock Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this News Release. This News Release contains forward-looking statements regarding a proposed private placement and the Company's activities, which statements can be identified by the words "will", "anticipates", and "developing". Actual results or events could differ materially from these forward-looking statements due to numerous factors, including without limitation, the risk that the proposed placement may not close as anticipated or at all, research & development risks, Helix's need for additional future capital, the risk of unanticipated expenses, and possible changes in business strategy or plans. These and other risks and uncertainties are contained in Helix's latest Annual Information Form at http://www.sedar.com'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
2. Helix BioPharma Chairman resigns
3. Helix BioPharma Corp. announces fiscal 2007 results
4. Helix BioPharma Corp. announces management changes
5. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
6. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
7. PDL BioPharma Announces Internal CEO Investigation Found No Credible Evidence of Improper Personal Conduct or Breach of Fiduciary Duty
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
10. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
11. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , BRIARCLIFF MANOR, N.Y., Nov. 30 /PRNewswir...idance document for the publication of company-spo... today by the British Medical Journal (BMJ). "The ...f the importance of providing support and guidance...on of study results in the peer-reviewed medical l...
(Date:11/30/2009)..., CHANGCHUN, China and LOS ANGELES, Nov. 30...maceuticals, Inc. (OTC Bulletin Board: CYXN; ,Chin...ading manufacturer, distributor and,retailer of ph...ed it has,completed preparation for distribution o... The Chinese government recently formalized the na...
(Date:11/30/2009)... PDS, a leader in providing smart a..., announces Pajama Pathology®, evolutionizing ...e ‘gold standard’ software used by 8 o..., but on a ‘cost per slide’ basis. , ...) November 30, 2009 -- PDS has announced another e...
(Date:11/30/2009)... , SHANGHAI, Nov. 30 /PRNewswire-Asia/ -- ...tical, biotechnology, and medical-device research ...s in China and the United States,announced that i...t 50 China,2009 list for the fifth consecutive yea...anies in China,s technology, media, and telecommun...
Breaking Biology Technology:ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 2ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 3China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2
... a great opportunity to observe technology adoptio... mobile phones are nearly ubiquitous, even if thei...to use their mobile with thumbs blazing, text mess...and, are primarily talkers. , ,Yet mobile phones r...e from neck cords. Some sport cute bangles. Most a...
...ing to suggest that scientists at UW-Madison or an.... They arent. In fact, no scientist in the state h...o be disingenuous to suggest the process for cloni... different at the outset -- from the process used...ocedures involves removing an eggs nucleus (the pa...
... and transportation firms are still popular among ...onday by Computerworld. , ,The magazine released...eport on Monday, ranking American Family Insuranc...al Inc . 61st. This year,s study recognized compan...reward high performance and encourage connections ...
Other Biology Technology:U.K. firm develops smart fabrics 2U.K. firm develops smart fabrics 3The Attack of the Clones: No, its not a summer movie 2The Attack of the Clones: No, its not a summer movie 3Two Wisconsin companies hold spots on Computerworld employee survey 2
(Date:11/26/2009)...ad researchers have developed a new type of geneti...s and proteins used by pathogens, according to the...ures genes are present in two copies: one inherite...activation by mutation is therefore inefficient be...y usually remains active and takes over. , In ye...
(Date:11/25/2009)...In addition to mammalian immune systems that besie...eriophages, viruses that kill half the bacteria on...other class of microorganisms called archaea (firs...sea volcanic vents) manage just fine, thank you, i... that helps protect them from many viruses and oth...
(Date:11/25/2009)...s recently received funding from the National Scie...al to understanding the environment. The three gra...istant professor in the Department of Biological S...e research projects. , His first project, titled...ctions from the Leaf to the Landscape," will exami...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Kent State University professors focus research on the environment with grants totaling $890,000 2ThermoGenesis Names Jorge Artiles Vice President Chief Quality and Regulatory Affairs Officer 5574 1ThermoGenesis Names Jorge Artiles Vice President Chief Quality and Regulatory Affairs Officer 5574 2ThermoGenesis Names Jorge Artiles Vice President Chief Quality and Regulatory Affairs Officer 5574 3Perrigo Company Will Release First Quarter Fiscal 2010 Results on November 2 2009 5572 1Four Pharmaceutical Companies Pay 24124 Million for Submission of False Claims to Medicaid 5570 1Four Pharmaceutical Companies Pay 24124 Million for Submission of False Claims to Medicaid 5570 2Four Pharmaceutical Companies Pay 24124 Million for Submission of False Claims to Medicaid 5570 3
...chnology,s Center for Maritime Systems began a pro...for Inundations in the Dominican Republic. The pro...,s EWS and providing the most up-to-date equipment...d prevent flooding on the island. , The genesis of...aveche, President of Stevens, was attending a meet...
...earchers at Sentara Cardiovascular Research Instit... safety and effectiveness of stents to open airway...bstructive Pulmonary Disease (COPD). , The EASE ... on airway bypass, an investigational technique wi...apped air from within diseased lung tissue, thereb...
...ynthetic hormones derived from the human male horm...pected in professional baseball and other sports w...ce, is paramount. Power lifting is such a sport. A...abolic steroid use on power lifters years after th...rchers found that while physical traces of the dru...
Other Biology News:Stevens strengthens Dominican Republic's Early Warning System for Inundations 2Stevens strengthens Dominican Republic's Early Warning System for Inundations 3Sentara begins international trial -- open at only 24 US locations 2Anabolic steroids provide a competitive edge in power lifting years after doping has ended 2Anabolic steroids provide a competitive edge in power lifting years after doping has ended 3
Mouse Anti-Aequorin Monoclonal Antibody, Unconjugated, Clone 2Q2147 from Abcam
Anti-Phosphotyrosine IgG Monoclonal Antibody, Alkaline Phosphatase Conjugated, Clone AD548 from Assay Designs/Stressgen Bioreagents
...A isomers are predominantly used for labeling prot...d for labeling peptides and nucleotides because th...t is often required in the conjugation processes. ...ng peptides and proteins. 6-TAMRA is predominately...
Chicken Anti-Lactate Dehydrogenase Antibody, Unconjugated from Immunology Consultants Laboratory, Inc.
Biology Products: